Related Experiment Video
Updated: May 8, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Early detection of cardiac involvement in thalassemia: From bench to bedside perspective
Nut Koonrungsesomboon1, Siriporn C Chattipakorn, Suthat Fucharoen
1Nut Koonrungsesomboon, Siriporn C Chattipakorn, Nipon Chattipakorn, Cardiac Electrophysiology Research and Training Center, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Insights
Myocardial siderosis in thalassemia major (TM) patients leads to fatal iron overload cardiomyopathy. Early detection via cardiac MRI and heart rate variability is crucial for preventing mortality in these patients.
Area of Science:
- Cardiology
- Hematology
- Medical Imaging
Background:
- Myocardial siderosis is a primary cause of death in thalassemia major (TM) patients, leading to iron overload cardiomyopathy.
- Despite chelation therapy, high mortality persists due to delayed detection of cardiac iron overload.
- Current iron assessment methods have limitations and controversial evidence in clinical practice.
Purpose of the Study:
- To comprehensively review and present all proposed methods for assessing cardiac iron status in TM patients.
- To discuss the efficacy and limitations of various direct and indirect iron assessment techniques.
- To highlight cardiac magnetic resonance imaging and heart rate variability for early detection.
Main Methods:
- Systematic review of basic and clinical studies on cardiac iron assessment in TM.
- Analysis of direct and indirect iron assessment methods: serum ferritin, echocardiogram, non-transferrin-bound iron, cardiac MRI T2*, heart rate variability, biopsies.
- Focused discussion on cardiac MRI and heart rate variability for early detection.
Main Results:
- Various methods exist for assessing cardiac iron overload, but clinical application is limited by controversy and evidence gaps.
- Cardiac magnetic resonance imaging (cardiac MRI) and heart rate variability (HRV) show promise for early detection of cardiac involvement.
- The review synthesizes existing data on these methods, addressing controversies in cardiac assessment for TM.
Conclusions:
- Early and accurate detection of cardiac iron overload is critical for improving survival in TM patients.
- Cardiac MRI and heart rate variability are emerging as valuable tools for the early diagnosis of cardiac complications in TM.
- Further research and standardization are needed to address controversies and optimize clinical use of these assessment methods.
Abstract:
Myocardial siderosis is known as the major cause of death in thalassemia major (TM) patients since it can lead to iron overload cardiomyopathy. Although this condition can be prevented if timely effective intensive chelation is given to patients, the mortality rate of iron overload cardiomyopathy still remains high due to late detection of this condition. Various direct and indirect methods of iron assessment, including serum ferritin level, echocardiogram, non-transferrin-bound iron, cardiac magnetic resonance T2*, heart rate variability, and liver biopsy and myocardial biopsy, have been proposed for early detection of cardiac iron overload in TM patients. However, controversial evidence and limitations of their use in clinical practice exist. In this review article, all of these iron assessment methods that have been proposed or used to directly or indirectly determine the cardiac iron status in TM reported from both basic and clinical studies are comprehensively summarized and presented. Since there has been growing evidence in the past decades that cardiac magnetic resonance imaging as well as cardiac autonomic status known as the heart rate variability can provide early detection of cardiac involvement in TM patients, these two methods are also presented and discussed. The existing controversy regarding the assessment of cardiac involvement in thalassemia is also discussed.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
